Patents by Inventor Gerald Henry NABOZNY

Gerald Henry NABOZNY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230265203
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: October 7, 2022
    Publication date: August 24, 2023
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Scott Ronald BRODEUR, Thomas B. FREEMAN, Gerald Henry Nabozny, Meera RAMANUJAM, Paul SCHOLL, Juergen STEFFGEN
  • Publication number: 20210317201
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: June 23, 2021
    Publication date: October 14, 2021
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Gerald Henry NABOZNY, Annette Bettina GALLER, Patrick GARIDEL, William Troy LOGING, Steven John PADULA, Torsten SCHULTZ-FADEMRECHT, Elaine Ee-Ling WANG
  • Patent number: 11078265
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: August 3, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Gerald Henry Nabozny, Annette Bettina Galler, Patrick Garidel, William Troy Loging, Steven John Padula, Torsten Schultz-Fademrecht, Elaine Ee-Ling Wang
  • Publication number: 20170058038
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: August 31, 2016
    Publication date: March 2, 2017
    Inventors: Scott Ronald BRODEUR, Thomas B. FREEMAN, Gerald Henry NABOZNY, Meera RAMANUJAM, Paul SCHOLL, Juergen STEFFGEN
  • Publication number: 20140178401
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: April 25, 2013
    Publication date: June 26, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Gerald Henry NABOZNY, Annette Bettina GALLER, Patrick GARIDEL, William Troy LOGING, Steven John PADULA, Torsten SCHULTZ-FADEMRECHT, Elaine Ee-Ling WANG